Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Myconic Capital Announces Closing of Mindscape Ketamine & Infusions Therapy Acquisition
MYCONIC CAPITAL CORP.April 22, 2021 GMT
VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) Myconic Capital Corp. (formerly, Auralite Investments Inc.) (CSE: MEDI) (FRA: MY0) (the “Company” or “Myconic”) is pleased to announce that, further to its press release of March 10, 2021, it has completed the acquisition of all of the issued and outstanding equity of Mindscape Ketamine & Infusions Therapy, PLLC (“Mindscape”) a mental health and pain clinic based in Houston, Texas. As a result, Myconic made a cash payment of US$50,000 and issued 94,292 common shares of Myconic (the “Payment Shares”) to the sole owner of Mindscape.
Houston
Texas
United-states
Canada
United-kingdom
Vancouver
British-columbia
British
Canadian
Quang-henderson
Robert-meister
Auralite-investments-inc